Original Articles and Brief Reports

Rapid clearance of rituximab may contribute to the continued high incidence of autoimmune hematologic complications of chemoimmunotherapy for chronic lymphocytic leukemia

Hematology Branch, NHLBI, NIH, Bethesda, MD, USA;Walter Reed National Military Medical Center, Bethesda, MD, USA
Hematology Branch, NHLBI, NIH, Bethesda, MD, USA
Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA, USA
Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA, USA
Hematology Branch, NHLBI, NIH, Bethesda, MD, USA
Hematology Branch, NHLBI, NIH, Bethesda, MD, USA
Hematology Branch, NHLBI, NIH, Bethesda, MD, USA
Metabolism Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA
Department of Biochemistry and Molecular Genetics, University of Virginia School of Medicine, Charlottesville, VA, USA
Hematology Branch, NHLBI, NIH, Bethesda, MD, USA
Vol. 98 No. 8 (2013): August, 2013 https://doi.org/10.3324/haematol.2012.080929